Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Cochlear ( (AU:COH) ) just unveiled an announcement.
Cochlear Limited has announced a change in the shareholding of its director, Michael del Prado, who has acquired 75 additional fully paid ordinary shares in the company. This purchase was made on the United States over-the-counter market, increasing his total holdings to 1,016 shares. This transaction reflects the director’s growing interest in the company and may signal confidence in its future performance.
The most recent analyst rating on (AU:COH) stock is a Hold with a A$327.00 price target. To see the full list of analyst forecasts on Cochlear stock, see the AU:COH Stock Forecast page.
More about Cochlear
Cochlear Limited operates in the medical device industry, focusing on the development and manufacturing of implantable hearing solutions. The company is known for its cochlear implants, which are designed to help individuals with severe to profound hearing loss. Cochlear primarily targets the global healthcare market, offering innovative solutions that enhance the quality of life for people with hearing impairments.
YTD Price Performance: 4.86%
Average Trading Volume: 178,382
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$19.72B
Learn more about COH stock on TipRanks’ Stock Analysis page.